Antibiotic bill doesn't GAIN enough ground - PubMed (original) (raw)
Antibiotic bill doesn't GAIN enough ground
Paul G Ambrose. Nat Med. 2011.
Abstract
With an eye to tackling the growing problem of antimicrobial drug resistance, uS lawmakers last month proposed new incentives to jump-start the ailing antibiotic industry. but the legislation as written is not likely to have the intended consequences, as it fails to adequately shield companies from competition with generic drugs. To truly entice investment and research from the drug industry, the bill needs to simplify the path to regulatory approval, provide greater protection from generic competition and aid drug companies with intellectual property extensions, tax relief and guaranteed market commitments.
Similar articles
- Generic drugs: the stalling game.
[No authors listed] [No authors listed] Consum Rep. 2001 Jul;66(7):36-40. Consum Rep. 2001. PMID: 11725791 - Lawsuits anticipated on generic biologicals front.
Fox JL. Fox JL. Nat Biotechnol. 2003 Jul;21(7):721-2. doi: 10.1038/nbt0703-721. Nat Biotechnol. 2003. PMID: 12833078 No abstract available. - Recent developments help the defense of drug companies in 10b-5 cases.
Salpeter AN, Hutchins H. Salpeter AN, et al. Food Drug Law J. 1996;51(3):345-53. Food Drug Law J. 1996. PMID: 11797711 No abstract available. - Accelerated approval of oncology products: the food and drug administration experience.
Johnson JR, Ning YM, Farrell A, Justice R, Keegan P, Pazdur R. Johnson JR, et al. J Natl Cancer Inst. 2011 Apr 20;103(8):636-44. doi: 10.1093/jnci/djr062. Epub 2011 Mar 21. J Natl Cancer Inst. 2011. PMID: 21422403 Review. - Follow-on biologics: data exclusivity and the balance between innovation and competition.
Grabowski H. Grabowski H. Nat Rev Drug Discov. 2008 Jun;7(6):479-88. doi: 10.1038/nrd2532. Epub 2008 May 12. Nat Rev Drug Discov. 2008. PMID: 18469828 Review.
Cited by
- A Broken Antibiotic Market: Review of Strategies to Incentivize Drug Development.
Bhavnani SM, Krause KM, Ambrose PG. Bhavnani SM, et al. Open Forum Infect Dis. 2020 Mar 13;7(7):ofaa083. doi: 10.1093/ofid/ofaa083. eCollection 2020 Jul. Open Forum Infect Dis. 2020. PMID: 32667365 Free PMC article. - Small molecule deubiquitinase inhibitors promote macrophage anti-infective capacity.
Charbonneau ME, Gonzalez-Hernandez MJ, Showalter HD, Donato NJ, Wobus CE, O'Riordan MX. Charbonneau ME, et al. PLoS One. 2014 Aug 5;9(8):e104096. doi: 10.1371/journal.pone.0104096. eCollection 2014. PLoS One. 2014. PMID: 25093325 Free PMC article. - Fresh approaches to anti-infective therapies.
Nathan C. Nathan C. Sci Transl Med. 2012 Jun 27;4(140):140sr2. doi: 10.1126/scitranslmed.3003081. Sci Transl Med. 2012. PMID: 22745440 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical